Tamilnad Mercantile Bank Ltd

Tamilnad Mercantile Bank Ltd company information, Employees & Contact Information

A scheduled commercial Private Sector Bank having 509 Branches located in 16 States and 4 Union Territories

Company Details

Employees
1.74K
Founded
-
Address
57 V E Road, Thoothukudi,tamil Nadu 628002,india
Industry
Banking
NAICS
Commercial Banking
HQ
Thoothukudi, Tamil Nadu
Looking for a particular Tamilnad Mercantile Bank Ltd employee's phone or email?

Tamilnad Mercantile Bank Ltd Questions

News

The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives - Journal of Hematology & Oncology

The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives Journal of Hematology & Oncology

Genomic characterization of tumor mutational burden-high breast carcinomas - Nature

Genomic characterization of tumor mutational burden-high breast carcinomas Nature

Differences in immunogenicity of TP53-mutated cancers with low tumor mutational burden (TMB) A study on TP53mut endometrial-, ovarian- and triple-negative breast cancer - ScienceDirect.com

Differences in immunogenicity of TP53-mutated cancers with low tumor mutational burden (TMB) A study on TP53mut endometrial-, ovarian- and triple-negative breast cancer ScienceDirect.com

Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis - Frontiers

Role of tumor mutational burden in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis Frontiers

Canby tops TMB in extras for 2nd straight last-inning win - marshallindependent.com

Canby tops TMB in extras for 2nd straight last-inning win marshallindependent.com

Informing health system planning for biomarker-based treatment: statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042 - The Lancet

Informing health system planning for biomarker-based treatment: statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042 The Lancet

TMA Calls for Increased Funding to Help TMB Address Workforce Issues - Texas Medical Association

TMA Calls for Increased Funding to Help TMB Address Workforce Issues Texas Medical Association

PD-L1, PD1, TMB and Lung Cancer - American Lung Association

PD-L1, PD1, TMB and Lung Cancer American Lung Association

Mutation Analysis of TMB-High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications - Wiley Online Library

Mutation Analysis of TMB-High Colorectal Cancer: Insights Into Molecular Pathways and Clinical Implications Wiley Online Library

A Systematic Review and Meta-Analysis of the Impact of Tumour Mutation Burden on Survival Outcomes in Solid Tumours - medRxiv

A Systematic Review and Meta-Analysis of the Impact of Tumour Mutation Burden on Survival Outcomes in Solid Tumours medRxiv

Biodegradation of 1,2,4-trimethylbenzene in seawater using Rhodomonas sp. JZB-2: Performance, kinetics, and mechanism - ScienceDirect.com

Biodegradation of 1,2,4-trimethylbenzene in seawater using Rhodomonas sp. JZB-2: Performance, kinetics, and mechanism ScienceDirect.com

Different NGS identification methods of somatic mutation sites in solid tumors impact TMB results - BMC Cancer

Different NGS identification methods of somatic mutation sites in solid tumors impact TMB results BMC Cancer

The first large TMB on the Salerno Reggio Calabria Rail line begins excavation - Global Railway Review

The first large TMB on the Salerno Reggio Calabria Rail line begins excavation Global Railway Review

Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness | JCO Precision Oncology - ASCO Publications

Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness | JCO Precision Oncology ASCO Publications

We spent 12 days on the greatest hiking trail in the world. You can, too. - The Boston Globe

We spent 12 days on the greatest hiking trail in the world. You can, too. The Boston Globe

Continuous prediction for tumor mutation burden based on transcriptional data in gastrointestinal cancers - BMC Medical Informatics and Decision Making

Continuous prediction for tumor mutation burden based on transcriptional data in gastrointestinal cancers BMC Medical Informatics and Decision Making

Co-dispersion of cellulose nanofibers and 3,3′,5,5′-tetramethylbenzidine in water: Different strategies for colorimetric probes - ScienceDirect.com

Co-dispersion of cellulose nanofibers and 3,3′,5,5′-tetramethylbenzidine in water: Different strategies for colorimetric probes ScienceDirect.com

microcubes as an alternative to peroxidase/TMB for colorimetric detection of H - ScienceDirect.com

microcubes as an alternative to peroxidase/TMB for colorimetric detection of H ScienceDirect.com

Tumor mutational burden in colorectal cancer: Implications for treatment - ScienceDirect.com

Tumor mutational burden in colorectal cancer: Implications for treatment ScienceDirect.com

Advanced Solid Tumors With High TMB in Both Tissue and Blood Experience Impressive ORR With Nivolumab/Ipilimumab - CancerNetwork

Advanced Solid Tumors With High TMB in Both Tissue and Blood Experience Impressive ORR With Nivolumab/Ipilimumab CancerNetwork

Measuring Tumor Mutational Burden (TMB) in Plasma from mCRPC Patients Using Two Commercial NGS Assays - Nature

Measuring Tumor Mutational Burden (TMB) in Plasma from mCRPC Patients Using Two Commercial NGS Assays Nature

Record 684m bus and metro journeys in Barcelona in 2024 - Catalan News

Record 684m bus and metro journeys in Barcelona in 2024 Catalan News

Tumor mutational burden is associated with poor outcomes in diffuse glioma - BMC Cancer

Tumor mutational burden is associated with poor outcomes in diffuse glioma BMC Cancer

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors - ScienceDirect.com

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors ScienceDirect.com

Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data - Frontiers

Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data Frontiers

The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis - ScienceDirect.com

The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis ScienceDirect.com

TMB or not TMB as a biomarker: That is the question - ScienceDirect.com

TMB or not TMB as a biomarker: That is the question ScienceDirect.com

Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis - Journal of Translational Medicine

Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis Journal of Translational Medicine

Dr. Zhu on TMB in Lung Cancer - OncLive

Dr. Zhu on TMB in Lung Cancer OncLive

Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer - ScienceDirect.com

Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer ScienceDirect.com

Clinical and technical insights of tumour mutational burden in non-small cell lung cancer - ScienceDirect.com

Clinical and technical insights of tumour mutational burden in non-small cell lung cancer ScienceDirect.com

OA01.04 Tumor Mutation Burden (TMB) by Next Generation Sequencing (NGS) Associates with Survival (OS) in Lung-MAP Immunotherapy Trials S1400I and S1400A - ScienceDirect.com

OA01.04 Tumor Mutation Burden (TMB) by Next Generation Sequencing (NGS) Associates with Survival (OS) in Lung-MAP Immunotherapy Trials S1400I and S1400A ScienceDirect.com

High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity - ScienceDirect.com

High tumor mutational burden (TMB) identifies a microsatellite stable pancreatic cancer subset with prolonged survival and strong anti-tumor immunity ScienceDirect.com

What is the status of immunotherapy in thyroid neoplasms? - Frontiers

What is the status of immunotherapy in thyroid neoplasms? Frontiers

Unanswered Questions With the Role of TMB in NSCLC - OncLive

Unanswered Questions With the Role of TMB in NSCLC OncLive

A bipartite graph-based expected networks approach identifies DDR genes not associated with TMB yet predictive of immune checkpoint blockade response - ScienceDirect.com

A bipartite graph-based expected networks approach identifies DDR genes not associated with TMB yet predictive of immune checkpoint blockade response ScienceDirect.com

Prognostic Role of Tumor Mutational Burden in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis - Frontiers

Prognostic Role of Tumor Mutational Burden in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis Frontiers

Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: a feasibility study - BMC Cancer

Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: a feasibility study BMC Cancer

Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma - ScienceDirect.com

Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma ScienceDirect.com

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma - Nature

Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma Nature

The Predictive Value of Tumor Mutation Burden on Clinical Efficacy of Immune Checkpoint Inhibitors in Melanoma: A Systematic Review and Meta-Analysis - Frontiers

The Predictive Value of Tumor Mutation Burden on Clinical Efficacy of Immune Checkpoint Inhibitors in Melanoma: A Systematic Review and Meta-Analysis Frontiers

Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer - Nature

Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer Nature

Molecular profiles and tumor mutational burden analysis in Chinese patients with gynecologic cancers - Nature

Molecular profiles and tumor mutational burden analysis in Chinese patients with gynecologic cancers Nature

Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images - Nature

Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images Nature

Tumor Agnostic Role of TMB Biomarker Faces Challenges - OncLive

Tumor Agnostic Role of TMB Biomarker Faces Challenges OncLive

Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays | npj Precision Oncology - Nature

Relationship among DDR gene mutations, TMB and PD-L1 in solid tumour genomes identified using clinically actionable biomarker assays | npj Precision Oncology Nature

Universal cutoff for tumor mutational burden in predicting the efficacy of anti-PD-(L)1 therapy for advanced cancers - Frontiers

Universal cutoff for tumor mutational burden in predicting the efficacy of anti-PD-(L)1 therapy for advanced cancers Frontiers

Bias and inconsistency in the estimation of tumour mutation burden - BMC Cancer

Bias and inconsistency in the estimation of tumour mutation burden BMC Cancer

Information for Patients on Tumor Mutational Burden - Cancer Therapy Advisor

Information for Patients on Tumor Mutational Burden Cancer Therapy Advisor

Colorimetric detection of Cr(VI) in water using tetramethyl benzidine (TMB) as an indicator - ScienceDirect.com

Colorimetric detection of Cr(VI) in water using tetramethyl benzidine (TMB) as an indicator ScienceDirect.com

A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients - BMC Medicine

A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients BMC Medicine

Molecular profiling of a bladder cancer with very high tumour mutational burden | Cell Death Discovery - Nature

Molecular profiling of a bladder cancer with very high tumour mutational burden | Cell Death Discovery Nature

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma - Cancer Cell International

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma Cancer Cell International

Multiomics analysis of tumor mutational burden across cancer types - ScienceDirect.com

Multiomics analysis of tumor mutational burden across cancer types ScienceDirect.com

Optimizing the evaluation of gene-targeted panels for tumor mutational burden estimation - Nature

Optimizing the evaluation of gene-targeted panels for tumor mutational burden estimation Nature

High tumor mutation burden indicates better prognosis in colorectal cancer patients with KRAS mutations - Frontiers

High tumor mutation burden indicates better prognosis in colorectal cancer patients with KRAS mutations Frontiers

Tumor mutation burden: from comprehensive mutational screening to the clinic - Cancer Cell International

Tumor mutation burden: from comprehensive mutational screening to the clinic Cancer Cell International

Characterization of pancreatic cancer with ultra-low tumor mutational burden | Scientific Reports - Nature

Characterization of pancreatic cancer with ultra-low tumor mutational burden | Scientific Reports Nature

Immunotherapy Approval in TMB-High Tumors Makes it More Accessible, Yet Questions Remain - Targeted Oncology

Immunotherapy Approval in TMB-High Tumors Makes it More Accessible, Yet Questions Remain Targeted Oncology

Guardant Health Presents Data on Immunotherapy-related Biomarkers MSI and TMB in blood of advanced cancer patients at European Society of Medical Oncology Annual Meeting - PR Newswire

Guardant Health Presents Data on Immunotherapy-related Biomarkers MSI and TMB in blood of advanced cancer patients at European Society of Medical Oncology Annual Meeting PR Newswire

The combination of tumor mutational burden and T-cell receptor repertoire predicts the response to immunotherapy in patients with advanced non–small cell lung cancer - Wiley Online Library

The combination of tumor mutational burden and T-cell receptor repertoire predicts the response to immunotherapy in patients with advanced non–small cell lung cancer Wiley Online Library

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy - Nature

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy Nature

Tumor Mutational Burden Can Help Predict Response to Immunotherapy in Many Different Cancers - Memorial Sloan Kettering Cancer Center

Tumor Mutational Burden Can Help Predict Response to Immunotherapy in Many Different Cancers Memorial Sloan Kettering Cancer Center

Pathogenic somatic alterations of DDR genes in lung cancer are significantly different from germline mutations and are associated with more unstable genomes - Journal of Translational Medicine

Pathogenic somatic alterations of DDR genes in lung cancer are significantly different from germline mutations and are associated with more unstable genomes Journal of Translational Medicine

Assam: Kamal Choudhury Sworn In as TMB Chairman, Vows Inclusive Development - The Sentinel - of this Land, for its People

Assam: Kamal Choudhury Sworn In as TMB Chairman, Vows Inclusive Development The Sentinel - of this Land, for its People

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial - Nature

Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial Nature

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing - BMC Cancer

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing BMC Cancer

Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB - Frontiers

Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB Frontiers

BYD to Supply 25 New Generation 40-foot Electric Buses to TMB in Barcelona - BYD USA

BYD to Supply 25 New Generation 40-foot Electric Buses to TMB in Barcelona BYD USA

TMB Notches 110% Revenue Growth and Plans 100 Hires to Fast-Track OTT Ambitions - ADWEEK

TMB Notches 110% Revenue Growth and Plans 100 Hires to Fast-Track OTT Ambitions ADWEEK

TMBcalc: a computational pipeline for identifying pan-cancer Tumor Mutational Burden gene signatures - Frontiers

TMBcalc: a computational pipeline for identifying pan-cancer Tumor Mutational Burden gene signatures Frontiers

POLE/POLD1 mutation and tumor immunotherapy - Journal of Experimental & Clinical Cancer Research

POLE/POLD1 mutation and tumor immunotherapy Journal of Experimental & Clinical Cancer Research

Clearing the Fog around Tumor Mutational Burden - Memorial Sloan Kettering Cancer Center

Clearing the Fog around Tumor Mutational Burden Memorial Sloan Kettering Cancer Center

NF1 mutations as biomarker of response to immune checkpoint blockades for lung adenocarcinoma patients - Nature

NF1 mutations as biomarker of response to immune checkpoint blockades for lung adenocarcinoma patients Nature

TMB-H Status Linked With High Responses to Dostarlimab in Endometrial Cancer - OncLive

TMB-H Status Linked With High Responses to Dostarlimab in Endometrial Cancer OncLive

TMB Can Vary Temporally, Spatially Within Patients - ASCO Daily News

TMB Can Vary Temporally, Spatially Within Patients ASCO Daily News

Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples - Nature

Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples Nature

Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis - Nature

Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis Nature

FDA Approves Pembrolizumab for TMB-High Tumors - OncLive

FDA Approves Pembrolizumab for TMB-High Tumors OncLive

Colorimetic biosensing dispositive based on reagentless hybrid biocomposite: Application to hydrogen peroxide determination - ScienceDirect.com

Colorimetic biosensing dispositive based on reagentless hybrid biocomposite: Application to hydrogen peroxide determination ScienceDirect.com

(PDF) The prognostic value of TMB in early-stage non-small cell lung cancer: a systematic review and meta-analysis - researchgate.net

(PDF) The prognostic value of TMB in early-stage non-small cell lung cancer: a systematic review and meta-analysis researchgate.net

Diagnosis and prognosis models for hepatocellular carcinoma patient’s management based on tumor mutation burden - ScienceDirect.com

Diagnosis and prognosis models for hepatocellular carcinoma patient’s management based on tumor mutation burden ScienceDirect.com

How to Hike the Tour du Mont Blanc: 3 Countries, 11 Mountain Passes, and All the Fresh-Baked Tarts You Can Eat - Outside Magazine

How to Hike the Tour du Mont Blanc: 3 Countries, 11 Mountain Passes, and All the Fresh-Baked Tarts You Can Eat Outside Magazine

Blood Test Predicts Response to Immunotherapy - Northwestern University

Blood Test Predicts Response to Immunotherapy Northwestern University

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma - BMC Cancer

Comprehensive analysis of genomic mutation signature and tumor mutation burden for prognosis of intrahepatic cholangiocarcinoma BMC Cancer

TMB Appoints Nicolle Zawacki as Senior Vice President of Sales and Marketing - citybiz

TMB Appoints Nicolle Zawacki as Senior Vice President of Sales and Marketing citybiz

Spontaneous mutations in the single TTN gene represent high tumor mutation burden - Nature

Spontaneous mutations in the single TTN gene represent high tumor mutation burden Nature

Barcelona is turning subway trains into power stations - Grist.org

Barcelona is turning subway trains into power stations Grist.org

ecTMB: a robust method to estimate and classify tumor mutational burden - Nature

ecTMB: a robust method to estimate and classify tumor mutational burden Nature

Panels and models for accurate prediction of tumor mutation burden in tumor samples - Nature

Panels and models for accurate prediction of tumor mutation burden in tumor samples Nature

The tumor mutational landscape of BRCA2 -deficient primary and metastatic prostate cancer - Nature

The tumor mutational landscape of BRCA2 -deficient primary and metastatic prostate cancer Nature

TMB Signs With A3 Artists Agency For Unscripted Content - Deadline

TMB Signs With A3 Artists Agency For Unscripted Content Deadline

IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation - Acta Neuropathologica Communications

IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation Acta Neuropathologica Communications

Use of Sleep Aids in Insomnia: The Role of Time Monitoring Behavior - Psychiatrist.com

Use of Sleep Aids in Insomnia: The Role of Time Monitoring Behavior Psychiatrist.com

Analysis of mutations in DNA damage repair pathway gene in Chinese patients with hepatocellular carcinoma - Nature

Analysis of mutations in DNA damage repair pathway gene in Chinese patients with hepatocellular carcinoma Nature

Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib - Nature

Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib Nature

TMB SCSE Result 2025, SCSE Merit List Release Date - Physics Wallah

TMB SCSE Result 2025, SCSE Merit List Release Date Physics Wallah

Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non–Small Cell Lung Cancer - Frontiers

Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non–Small Cell Lung Cancer Frontiers

TMB Recruitment 2023, Apply Online Till 06 November - Physics Wallah

TMB Recruitment 2023, Apply Online Till 06 November Physics Wallah

Tour du Mont-Blanc Trek – Gear Selection Preview - Road Trail Run

Tour du Mont-Blanc Trek – Gear Selection Preview Road Trail Run

Top Tamilnad Mercantile Bank Ltd Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant